#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer limited stage Deafness Hodgkin's disease Autoimmune disorder VEXAS syndrome Lymphatic malformation Hereditary optic atrophy Dementia with Lewy bodies Acute promyelocytic leukaemia Cholangiocarcinoma Transitional cell cancer of the renal pelvis and ureter IPEX syndrome Vaginal cancer Glioblastoma multiforme Gaucher's disease type I More trials…

    Learn about Rare Diseases

    Activated PI3 kinase delta syndrome – Trials in Disease Lymphangiosarcoma Idiopathic pulmonary fibrosis Glomerulonephritis membranous – Diagnostics Marginal zone lymphoma refractory Cystic fibrosis – Trials in Disease Lysosomal storage disorder – Basic Information Immunodeficiency congenital – Basic Information Glomerulonephritis membranous Bronchiolitis obliterans syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GVV858 LUMC-BOB1-B7-TCR.1 Losmapimod Rosuvastatin Calcium Db-1303 Alpha-Tocopherol Ceftazidime Pentahydrate Trametinib ADX-324 Ep0031 Inupadenant Hydrochloride Toripalimab Alx148 Star-0215 Memantine Hydrochloride INSULIN DETEMIR Enfortumab Vedotin Oxytocin Synthetic Etrinabdione Venetoclax More therapies…

    Learn about Your Condition

    Combined immunodeficiency Pharyngeal cancer stage II Eyelid ptosis Renal transplant Cryoglobulinaemia Nervous system disorder Oral lichen planus Periarthritis Urethral valves Narcolepsy Hypothyroidism Cardiac disorder Cardiac ventricular thrombosis Oesophagectomy Oesophagogastroscopy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute cardiac event

  • Study on the Effects of Zalunfiban for Patients with ST-Elevation Myocardial Infarction (Heart Attack)

    Not recruiting

    3 1
    Investigated Diseases:
    • Acute cardiac event
    • Myocardial ischaemia
    • Acute myocardial infarction
    Investigated Drugs:
    • Zalunfiban
    Czechia France Hungary The Netherlands Romania

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!